In the midst of a global pandemic, sharing of scientific data is critical to increasing our collective understanding of SARS-CoV-2 and the resultant disease caused by the virus, COVID-19. We’d like to thank the researchers who are currently sharing their data through the ImmPort platform, and we stand ready to support the scientific community’s future data sharing and processing needs.
ImmPort’s latest data release includes 13 new studies and 2 updated studies, covering a wide range of focus areas including COVID-19, organ transplantation, auto-immune disease, influenza, cancer, and preterm birth. New shared studies include:
- SDY1641 Renin-angiotensin System Inhibitors Improve the Clinical Outcomes of COVID-19 Patients with Hypertension
- SDY1632 T cell and Chemokine Receptor Control of CD8 T Cell Motility after Influenza Infection
- SDY1414 Alloantibodies in Pediatric Heart Transplantation
- SDY1637 Immune Phenotyping of Diverse Syngeneic Murine Brain Tumors Identifies Immunologically Distinct Types
- SDY1658 A Comparative CyTOF Analysis of Resected-tumor Samples from Human GBM Patients and Mouse GBM-tumors
- SDY1618 Superior Mouse Eosinophil Depletion in Vivo Targeting Transgenic Siglec-8 Instead of Endogenous Siglec-F: Mechanisms and Pitfalls
- SDY1627 Single-Site, Five-Year Experience with Human Eosinophil Isolation by Density Gradient Centrifugation and CD16 Immunomagnetic Negative Separation
- SDY1656 Sublingual Cockroach Safety Study
- SDY1657 The Underlying Mechanisms for S. Aureus Infection and Colonization of Skin in People with Atopic Dermatitis with and without Eczema Herpeticum
- SDY1626 Transcriptome and Regulatory Maps of Decidua-derived Stromal Cells Inform Gene Discovery in Preterm Birth
- SDY1636 Crowdsourcing Assessment of Maternal Blood Multi-omics for Predicting Gestational Age and Preterm Birth
- SDY1642 Establishment of Vaginal Microbiota Composition in Early Pregnancy and its Association with Subsequent Preterm Prelabor Rupture of the Fetal Membrane
- SDY1649 Cervicovaginal Microbiota and Local Immune Response Modulate the Risk of Spontaneous Preterm Delivery
For a detailed listing of all studies shared or updated through ImmPort’s latest release, please see ImmPort’s Data Release Notes.
Additionally, we are actively working on the next COVID-19 data release. Please contact immport_COVID19@immport.org for more information about sharing your scientific data through the ImmPort platform. ImmPort is sponsored by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Disease (NIAID) and is a recommended data repository by PLOS One, Nature’s Scientific Data, and holds the Core Trust Seal of Approval for Core Trustworthy Data Repositories.